# Pharmacy Times

> Pharmacy Times - Healthcare Publication

- Base URL: https://www.pharmacytimes.com
- Generated: 2026-10-18T21:24:05.412Z
- Content updates: multiple times daily

## Content Access for AI Agents

This site supports content negotiation for AI/LLM consumption. Request any article URL with an appropriate Accept header to receive structured content instead of HTML.

**Supported content types:**
- `text/markdown` — Clean Markdown with YAML frontmatter
- `text/plain` — Plain text (same as Markdown)
- `text/html` — Default HTML response

**Example request:**
```
curl -H "Accept: text/markdown" https://www.pharmacytimes.com/view/article-slug
```

**YAML frontmatter schema** (returned with every Markdown response):

| Field | Type | Description |
|-------|------|-------------|
| `title` | string | Article headline |
| `description` | string | Summary/excerpt (max 300 chars) |
| `url` | string | Canonical article URL |
| `canonical_url` | string | Canonical URL if different from `url` |
| `published` | ISO 8601 | Original publication date |
| `modified` | ISO 8601 | Last modification date |
| `authors` | string[] | Author display names |
| `content_type` | string | Content category (e.g., "News", "Clinical") |
| `categories` | string[] | Taxonomy categories |
| `tags` | string[] | SEO tags |
| `image` | string | Featured image URL |
| `publisher` | string | Publication/site name |

**Discovery headers** (included on all responses):
- `Link: <https://www.pharmacytimes.com/llms.txt>; rel="llms"` — RFC 8288 link to this file
- `X-Llms-Txt: https://www.pharmacytimes.com/llms.txt` — Explicit discovery header

## Usage Policy

- Robots policy: [https://www.pharmacytimes.com/robots.txt](https://www.pharmacytimes.com/robots.txt)
- Cache behavior: responses are cached for ~5 minutes (max-age=300, stale-while-revalidate=329)
- Rate guidance: prefer RSS and sitemap feeds over crawling individual pages
- Attribution: All content © MJH Life Sciences. Include source URLs when citing.

## Content Categories

- [Additional Videos](https://www.pharmacytimes.com/additional-vidoes)
- [American Heart Month](https://www.pharmacytimes.com/american-heart-month)
- [American Pharmacists Month](https://www.pharmacytimes.com/american-pharmacists-month)
- [Clinical](https://www.pharmacytimes.com/clinical)
- [Clinical Role](https://www.pharmacytimes.com/clinical-role)
- [Conference](https://www.pharmacytimes.com/conference)
- [Educated Patient](https://www.pharmacytimes.com/educated-patient)
- [FDA Updates](https://www.pharmacytimes.com/fdaupdates)
- [Independent Corner](https://www.pharmacytimes.com/independent-corner)
- [Insights](https://www.pharmacytimes.com/insights)
- [Interviews](https://www.pharmacytimes.com/interviews)
- [Medcast](https://www.pharmacytimes.com/medcast)
- [News](https://www.pharmacytimes.com/news)
- [No Ads](https://www.pharmacytimes.com/no-ads)
- [OTC Guide](https://www.pharmacytimes.com/otcguide)
- [Peer Exchange](https://www.pharmacytimes.com/peer-exchange)
- [Peer-Reviewed Oncology Articles](https://www.pharmacytimes.com/peer-reviewed-oncology-articles)
- [Pharmacist to Pharmacist](https://www.pharmacytimes.com/p2p)
- [Podcasts](https://www.pharmacytimes.com/podcasts)
- [Practice Pearls](https://www.pharmacytimes.com/practice-pearls)
- [Pressroom](https://www.pharmacytimes.com/press-releases)
- [Publications](https://www.pharmacytimes.com/publications)
- [Pulse Point](https://www.pharmacytimes.com/pulse-point)
- [Rules](https://www.pharmacytimes.com/rules)
- [SAP News](https://www.pharmacytimes.com/sap-news)
- [Sponsored](https://www.pharmacytimes.com/sponsored)
- [Student Voices](https://www.pharmacytimes.com/student-voices)
- [The Bispecifics Network](https://www.pharmacytimes.com/the-bispecifics-network)
- [Topics](https://www.pharmacytimes.com/topics)
- [Webinars](https://www.pharmacytimes.com/webinars)
- [Week In Review](https://www.pharmacytimes.com/week-in-review)

## Featured Content

- [Breast Cancer Treatment Ends, But The Medication Questions Don’t](https://www.pharmacytimes.com/view/breast-cancer-treatment-ends-but-the-medication-questions-don-t): After initial breast cancer treatment, pharmacists can help patients navigate ongoing endocrine therapy, manage persistent adverse effects, and addres...
- [Diuretics, eGFR, and Intensive BP Lowering in CKD: What to Watch ](https://www.pharmacytimes.com/view/diuretics-egfr-and-intensive-bp-lowering-in-ckd-what-to-watch): Parminder K. Judge, PhD, explains why eGFR and electrolytes should be monitored when diuretics are added to reach intensive BP targets in patients wit...
- [Researchers Target Viral Fusion for Universal Flu, HIV Vaccines](https://www.pharmacytimes.com/view/researchers-target-viral-fusion-for-universal-flu-hiv-vaccines): The project maps how flu and HIV proteins enter cells, with the aim of developing longer-lasting vaccines.
- [5 Breast Cancer Advances in 2026—And The Questions They Leave Unanswered](https://www.pharmacytimes.com/view/5-breast-cancer-advances-in-2026-and-the-questions-they-leave-unanswered): Five breast cancer treatment advances in 2026 expand therapeutic options while raising questions.
- [VAX-31 Meets All Primary End Points vs PCV20 and PCV21 in Pivotal Phase 3 OPUS-1 Trial](https://www.pharmacytimes.com/view/vax-31-meets-all-primary-end-points-vs-pcv20-and-pcv21-in-pivotal-phase-3-opus-1-trial): VAX-31 met all primary end points against PCV20 and PCV21 in the pivotal phase 3 OPUS-1 trial.
- ["I Don't Feel Anything Yet": Managing Patient Expectations About Medication Timelines](https://www.pharmacytimes.com/view/-i-don-t-feel-anything-yet-managing-patient-expectations-about-medication-timelines): Pharmacy teams can prevent early discontinuation by setting clear expectations for when—and how—a medication's benefit will become apparent.
- [FDA Approves Zilucoplan Autoinjector for Myasthenia Gravis](https://www.pharmacytimes.com/view/fda-approves-zilucoplan-autoinjector-for-myasthenia-gravis): The once-daily device, bioequivalent to the existing prefilled syringe, gives adults with AChR antibody-positive generalized MG a second self-injectio...
- [Finerenone in Heart Failure: Evidence and Practice a Year Later](https://www.pharmacytimes.com/view/finerenone-in-heart-failure-evidence-and-practice-a-year-later): A year after FDA approval in heart failure (HF) with LVEF of 40% or higher, new ACC guidance and trial subanalyses are shaping how pharmacists use fin...
- [Using Cystatin C and Clinical Judgment to Dose Medications in Special Populations](https://www.pharmacytimes.com/view/using-cystatin-c-and-clinical-judgment-to-dose-medications-in-special-populations): The panel discusses when cystatin C–based eGFR equations can improve kidney function estimates for drug dosing in older adults and patients with obesi...
- [Weighing Dosing Thresholds and EHR Integration in the Move to eGFR](https://www.pharmacytimes.com/view/weighing-dosing-thresholds-and-ehr-integration-in-the-move-to-egfr): The panel explains how to weigh safety and efficacy near kidney function dosing thresholds and how pharmacists can work with informatics teams to buil...

## Feeds and Indexes

- [RSS Feed](https://www.pharmacytimes.com/rss.xml): Latest articles in XML syndication format
- [Sitemap](https://www.pharmacytimes.com/sitemap.xml): Complete URL index for all published pages
- [News Sitemap](https://www.pharmacytimes.com/sitemap-news.xml): Recent articles optimized for news indexing
- [Authors Directory](https://www.pharmacytimes.com/authors): Browse all contributors and their published work